Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
Review Article
Sarcopenia in Gastric Cancer
Author(s): Leping Li*, Zhen Fang and Liang Shang
Gastric Cancer (GC) is one of the common malignant tumors. Although treatment of GC has improved, overall survival remains low. The main treatment for GC is gastrectomy. Finding the risk factors affecting the prognosis after gastrectomy and taking active treatment and intervention measures are of great significance to improve the prognosis of gastric cancer. Sarcopenia comes from the greek sarx (muscle) and penia (loss). It was first proposed by Professor Rosenberg in 1989.
The prominent feature of sarcopenia is decreased skeletal muscle mass and function. Many studies have shown that sarcopenia is closely related to the prognosis of GC patients. Many international organizations studying sarcopenia have reached consensus and established cut off points for the diagnosis of sarcopenia. Currently, sarcopenia has been officially recognized as a muscle disease with the diagnosis .. View More»